|
|
| home about us advertise with us downloads links privacy contact us site map copyright policy |
| ||
GASTROINTESTINAL DRUGS (2Describe neural, paracrine and endocrine regulation of gastric acid production, H+,K+-ATPase activity, and concept of acid-peptic aggression vs. mucosal defense. Describe the role and mechanism of H. pylori in the development of peptic ulcers. Describe the role and mechanism of NSAIDS in the development of peptic ulcers. 1) Explain mechanisms by which H2 antagonists inhibit acid production. 3) Explain mechanisms by which certain H2 antagonists alter responses to other drugs. 4) Identify adverse effects, especially those related to age or gender, and consequences of cessation of therapy on the course of the disease. 4) Identify the major adverse reactions to major classes of drugs: diarrhea, constipation, acid-base balance, phosphate depletion, acid rebound, milk-alkali syndrome, effects on absorption of other drugs. Discuss appropriate use of laxatives to treat constipation (include the laxative abuse syndrome). 7. Drugs for the Treatment of Irritable Bowel Syndrome (IBS)untitledWhat is foodborne disease? Foodborne disease is caused by consuming contaminated foods or beverages. Many different disease-causing microbes, or pathogens, can contaminate foods, so there are many different foodborne infections. In addition, poisonous chemicals, or other harmful substances can cause foodborne diseases if they are present in food. More than 250 different foodborne diseases have been described. Most of these diseases are infections, caused by a variety of bacteria, viruses, and parasites that can be foodborne. These different diseases have many different symptoms, so there is no one "syndrome" that is foodborne illness. Chemical irritation of the gut or non-infectious bowel disease can also result in diarrhea. - Functional bowel disorders, such as irritable bowel syndrome, in which the intestines do not work normally. sd-01-en-03-18-2004-p65.p65We welcome members from all countries who are interested in scleroderma or related illnesses. The ISN is a registered nonprofit 501(C)(3) and our Federal Tax ID (EIN) is 26-0039428. ß ß ß ß ß ISN Annual Membership Enclosed is $25 or more (U.S. funds) to receive the ISN Insider newsletter by email, or $35 to receive it by postal mail. Donation - Special Please contact me, as I'd like to make a special donation or bequest. Please mail this form with payment made out to: Systemic Scleroderma Symptoms Please consult your doctor if you have two or more of the following symptoms, which are sometimes due to systemic sclerosis (scleroderma). Systemic sclero-derma may disqualify a person for life and/or health insurance in some countries. Circulation ß Swelling of hands, feet and/or face ß Raynaud's: fingers and/or toes turn white or blue due to cold or stress ß Ulcers (sores) on fingertips or toes Gastrointestinal ß Difficulty swallowing ß HeartburnWomens issues slid ekitBetween 4% and 10% of school-age children have migraines, and one in five adults with migraine report that their headaches began before age 10. Before puberty the prevalence of migraine is higher in boys than in girls. By their early 20s, however, women have an incidence of migraine three times higher than that in men.1 The American Migraine Study II sent questionnaires to 20,000 American households.2 Responses indicated a migraine prevalence of 18.2% for women and 6.5% for men. Women are also more likely than men to suffer severe functional disability from migraine.3 Of the estimated 28 million migraineurs in the U.S., approximately 20 million are female. The highest incidence of migraine in women occurs between the ages of 25 and 55 -- the most productive years of their lives. Furthermore, women in their 30s tend to have an increase in the severity as well as the frequency of attacks. After approxi-mately age 40, the prevalence of migraine tendsCMEC8 Extracted Ratified MinutesConflict of interest forms were completed by the members and handed to the Acting Chairperson. The first meeting was held on the evening of 10 June 1998 by teleconference. The order was established using the number of adverse drug reaction reports, the kind of association between the product and the reaction and the prevalence of the substance on the market. Those herbs that are in the largest number of products on the market will be considered first. Where there are only one or two products then sponsors will be contacted to see if the herb is on the market. The aim is to consider herbs that are in products frequently used and for which more information should be obtained. The instruction should state that the product must be mixed with fluids before consumption because of the potential for oesophageal rupture or irritation, although there were no reports of such problems in the briefing paper. purpose of the application is to legitimise the current label claimsThe research interests within the School are diverse, reflecting the multi-disciplinary nature of the academic staff. Highlights of the Year The major highlight of the year was a randomised, placebo-controlled clinical trial of a marine extract in mild to moderate asthma using a cross-over design. The study was funded by Faulding and undertaken by the School in partnership with the Southern Cross Institute for Health Research (a joint venture between Southern Cross University and the Northern Rivers Area Health Service) and the University of Queensland. The study involved an intensive recruitment phase to obtain volunteers who met the inclusion criteria, which included a salbutamol challenge to establish airway reversibility. This provided a homogenous group of subjects with physiologically demonstrated asthma. The first phase of the study ran over nine weeks and was undertaken as a multi-centre study with clinics in Lismore, Ballina, Casino, Tweed, Coffs Harbour and Bandolier 79Regular visitors to the Bandolier Internet will have seen a number of changes over the last few months. There will be more in coming months, as Internet Bandolier becomes much, much more than an electronic form of the paper edi-tion. Thirty one specialist subsections, where we have brought together topics featured in Bandolier and ImpAct and subdivided them for easy access. The intention is to keep the Internet site growing much faster than we can deliver information through the paper version. For several of these we have obtained sponsorship to allow rapid accretion of evidence where it exists: Management is supported by the NHSE. The Oxford Pain Internet Site was previously sponsored by the BUPA foundation and MSD to get it started, and re-sults of more meta-analyses and other evidence continue to be added. Systematic reviews and other evidence on comple-mentary and alternative therapy are being abstracted and added to the site. Irritable bowel syndrome (IBS) is said020410SUNY Upstate Medical University will hold a memorial service honoring individuals who have donated their bodies to help in the education of medical students on Thursday, April 11 at 7 p.m. in the ninth floor auditorium of Weiskotten Hall. All Upstate individuals are welcome to attend the service. topic of the next Nursing Enhancement Program to be offered Saturdays, April 27 and May 4 from 8:30 a.m. to noon at the Wyndham Syracuse on Carrier Circle. The same program will be presented on both dates. The program is designed for RNs, LPNs, GNs, nursing students and other nurses who work in hospitals, long-term care facilities, schools, community health settings, private offices, and industrial health settings It is approved for 3.6 contact hours by SUNY Upstate's Institute for Continuing Nursing Education. The program will review the many types of radiolog-ical diagnostic studies preformed on patients. Professionals from Upstate's Departments359Background: Atopy and allergic rhinitis are thought to be increased in preva-lence in chronic fatigue syndrome (CFS). Allergies have been proposed as an inciting pathogenic mechanism in chronic fatigue syndrome (CFS). Chronic fatigue syndrome subjects complained of dyspnea symptoms, but were not found to have clinical signs of asthma. Positive chronic fatigue syndrome scores were higher than AR scores. These results are not a validation for the use of this self-report questionnaire as a diagnostic tool to define chronic fatigue syndrome. In the same fashion, symp-tomatic overlap between atopic syn-dromes such as contact dermatitis, asthma, gastrointestinal food anaphy-laxis with CFS-related cutaneous symptoms, dyspnea, irritable bowel syndrome, and other syndromes should be viewed as manifestations of sepa-rate disease processes leading to simi-lar clinical pictures, but not allergic The high rate of rhinitis and sinusitis com-plaints in the CFS 2 group that made up 65% ofGiven 2.06Given Imaging at Digestive Disease Week (DDW®), the largest professional gathering Reflecting the dramatic increase in of GI professionals worldwide, held this Capsule Endoscopy procedures performed year in Orlando, Florida, USA. Given worldwide since last DDW, this years' Imaging is continuing its leadership role as conference features a record number of the driving force in advances in products Capsule Endoscopy activities. The focal and services for the only non-invasive, point is the Given Imaging booth with a ambulatory, diagnostic modality to wide variety of resources for GI specialists. Get a complete listing of all Capsule Endoscopy scientific sessions and events at DDW--visit the Given Imaging booth #1643 or the website www.givenimaging.com Visit one of the 18 multi-lingual workstations Get hands-on Capsule Endoscopy experience with: Hot off the press, the full Proceedings from the 2nd International Conference on Capsule Endoscopy (ICCE) 2003 is now availableABOUT THE CONFERENCE: Primary care providers are on the front line for many gastrointestinal tract and liver diseases. During the past few years, the principles and practice of Gastroenterology and Hepatology have continued to change and evolve at an extremely rapid pace. Clinical diagnostic and therapeutic advances have provided tremendous opportunities for our patients to have a more successful outcome for their illnesses. This course will review recent advances in the appropriate use of diagnostics and therapeutics in digestive and liver diseases. TARGET AUDIENCE: This course is designed for primary care physicians, physician assistants, nurse practitioners, nurses, and other healthcare providers. Upon completion of the course, the participant will: - Better understand the Current Guidelines for the Medical and Surgical treatment of Obesity and the common complications of these approaches. PerfectionismMPPurpose The purpose of this paper is to discuss current research regarding the construct of perfectionism, its measurement, its linkage with intellectual giftedness, and strategies for overcoming its negative effects. The Construct of Perfectionism In the past decade, clinicians have focused on the debilitating effects of perfectionism or perfectionistic thinking. For example, perfectionism has been identified as a possible cause of abdominal pain in children, alcoholism, anorexia, chronic olfactory paranoid syndromes, depression in children and adults, dysmorphophobia, erectile dysfunction, irritable bowel syndrome, Munchausen syndrome, obsessive compulsive personality disorders, Type A coronary-prone behavior, ulcerative colitis, and writer's block (Pacht, 1984). One of the difficulties in describing the construct of perfectionism is recognizing the multiple uses that occur in the literature. There is a fine line between striving to reach high standards of excellence andNo Slide TitleDolores Cahlores Cahill (relocating from Max Pill (relocating from Max Plank ank l UnUnderderththee Directorship Directorshipd in partnership with Servied in partnership with Servier a €13.5 million awarr a €13.5 million award to specialise in d to specialise in Institute) anInstitute) an technologies to treat cardiovascular disease.technologies to treat cardiovascular disease. Fergus Shanahan and d Gd Gaamble mble a €€ ical scientist, Profical scientist, Profd to research drud to research drugg UnUnderderththee Directorship Directorshipof biologist and clinof biologist and clin16.5 million awar16.5 million awareatments includingeatments includingCCrohrohnn's disease an's disease and d in partnership with Procter anin partnership with Procter antical productstical productsian trn tr treatments and phtreatments and pharmaceuarmaceu i irritable bowel syndrome.irritable bowel syndrome. of Innsbruck aof Innsbruck a€€12 million12 millionawaward to carry ouard to carry315801881WHRC_NewsletterSummer2004She's a veteran of the mall walker program sponsored by Baptist Health, having participated since 1983. She joins about 150 other walkers Mondays, Wednesdays and Fridays in front of Burdines-Macy's Home Store. From 9-10 a.m., an exercise specialist leads them on a walk through Dadeland Mall. The walking program is just one of many fitness and exercise programs offered by Baptist Health. Women often avoid getting mammograms because they are afraid of the pain, but the fear is unfounded, according to a recent report in the Archives of Internal Medicine. The study was based on interviews with 200 women over the age of 40 immediately after they had mammo-grams. About 72 percent of them had pain, but most char-acterized it as mild. Those who reported pain rated it on a scale of one ("no pain") to 10 ("the worst pain you've ever felt"). If you'd like to know more, come to a free program, "Irritable Bowel Syndrome: Yo u're in Charge," with gas-troenterologist Hugo Rams, M.D.,California Pacific Liver Review: Liver Disease Management & Transplantation ServicesApproximately one-third of U.S. patients infected with human immunodeficiency virus (HIV) are co-infected with hepatitis C virus (HCV). Research is underway to better understand the simultaneous management of these infections and resulting liver disease progression. "There are many similarities between HIV and HCV," says Natalie Bzowej, MD, PhD, of California Pacific Medical Center's Liver Disease Management and Transplant Program. "Both are single-stranded RNA viruses that share a similar genome structure. However, the protease inhibitors used in the successful treatment of HIV have no beneficial effect on HCV." HCV is the only member of the genus Hepacivirus in the Flaviviridae family (see diagram). The HCV genome has a single large open reading frame that encodes a 3,000 amino acid polyprotein that is cleaved into 10 structural or nonstructural proteins by proteases. As the most common of the 20 functional gastrointestinal (GI) disorders, irritable bowelNovartis Fact Sheet FinalNovartis ordinary shares are listed on the Swiss stock exchange and are traded on the SEAQ International, London. As a convenience, the translation rate of 1.55 from CHF (Swiss francs) to U.S. dollars may be used. This rate should not be construed as a representation that the Swiss franc amounts actually represent such U.S. dollar amounts as would be converted into U.S. dollars at the rate indicated or at any other rate. Full Dollar Reporting of Novartis financials anticipated to start with the first quarter of fiscal 2003. A third share buy back program was initiated in July to repurchase shares in a second trading line on the SWX Swiss Exchange. *GLIVEC (imatinib) outside the US The Novartis Pharmaceuticals Division is a world leader in the discov-ery, development, manufacture and marketing of prescription medicines. Our goal is to provide a broad portfolio of innovative, effective and safe products and services to patients through healthcare professionals around theXASIM_Master_5_7_pLearmanPURPOSE : To review an integrated approach to management of patients with chronic pelvic pain (CPP). EPIDEMIOLOGY : CPP is believed to affect 4% to as many as 40% of women who seek pri-mary care, making this symptom at least as common as asthma and back pain. This article addresses effective treatment of CPP, which requires parallel consideration of 3 factors: addressing underlying conditions that were initially responsible for the pain, ameliorating secondary muscular reactions that may become a con-tinuing sour ce of pain, and optimizing emotional well-being. Treatment endpoints are minimization of pain and psychologic distress and improve-ment in functioning--not necessarily cure or determination of a definitive diagnosis. A multidisciplinar y, integrative approach is needed that considers CPP as encom-passing a spectrum of potentially coexisting diseases and conditions. The gastroen-terologic approach traditionally encompasses colonoscopy or sigmoidoscopy, dietary1 | 2 | 3
| 4 | 5 | 6
| 7 | 8 | 9
| 10 | 11 | 12
| 14 | 15 | | ||
